U.S. DOD/CDMRP: Breast Cancer Research Program (BCRP)– LOI

Breakthrough Award Level 1 and 2 II:

Supports promising research with high potential to lead to or make breakthroughs in breast cancer. The impact may be near-term or long-term but must go beyond a minor advancement and have the potential to lead to a fundamentally new strategy or approach for preventing or ending breast cancer that is significantly more effective than current strategies or approaches. Funding: up to $3.35M for 4 years

Clinical Research Extension Award II

• Intended to increase the clinically relevant impact of breast cancer patient participation in clinical research by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysisFunding: to $8.4M for 4 years

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=663101